VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IINNInspira Technologies OXY B.H.N. Ltd.
$2.01$54M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

IINN logoInspira Technologies OXY B.H.N. Ltd.(IINN)Earnings, Financials & Key Ratios

IINN•NASDAQ
$2.01
Price updated Jun 27, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryRespiratory and sleep therapy devices
AboutInspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.Show more
  • Revenue$289K
  • EBITDA-$13M-115198.8%
  • Net Income-$13M-119505.5%
  • EPS (Diluted)-0.45-74900.0%
  • Gross Margin-94.12%
  • EBITDA Margin-4555.36%
  • Operating Margin-4710.73%
  • Net Margin-4574.39%
  • ROE-397.89%-181007.5%

IINN Price & Volume

Inspira Technologies OXY B.H.N. Ltd. (IINN) stock price & volume — 10-year historical chart

Loading chart...

Persistent R&D Burn Challenges Commercialization Growth Path

Investment Thesis • Updated 2025Q2

VerdictNegative
Growth:Mixed
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Capital dilution and regulatory failure
"Inspira Technologies remains in a high-risk, pre-commercial phase, characterized by a structural reliance on capital markets to fund its $1.8 million quarterly R&D expenditure. While the company is attempting to transition toward commercializing its Augmented Respiration Technology, the lack of meaningful revenue generation—totaling only $144.5K in 2025Q2—leaves the firm vulnerable to significant dilution. Investors should monitor the company's ability to secure regulatory milestones, as the current $2.1 million cash position provides a limited runway against ongoing operating losses."

Verdict Logic

the company's precarious liquidity position, highlighted by a $2.1 million cash balance against quarterly operating losses of $3.6 million, suggests an imminent risk of dilutive capital raises that could significantly impair shareholder value.

IINN Growth Metrics

Inspira Technologies OXY B.H.N. Ltd. (IINN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-15.75%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM28.74%

Return on Capital

10 Years-2988.14%
5 Years-104.84%
3 Years-164.81%
Last Year-377.28%

Peers Comparison

Key metrics vs top competitors for Inspira Technologies OXY B.H.N. Ltd. (IINN)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
IINN logoIINNInspira Technologies OXY B.H.N. Ltd.Current
$2.01$53.83M-4.47—-4574.39%-397.89%—
AVAV logoAVAVAeroVironment, Inc.
$137.95$6.89B89.0014.5%-13.93%-6.41%—
LUNG logoLUNGPulmonx Corporation
$1.31$55.12M-0.988.01%-60.09%-92.94%—
SPRO logoSPROSpero Therapeutics, Inc.
$2.26$130.86M15.0724.27%27.82%35.58%—
GMED logoGMEDGlobus Medical, Inc.
$86.25$11.63B22.0016.65%18.92%13.04%—
INVA logoINVAInnoviva, Inc.
$23.57$1.74B7.1418.52%118.91%47.59%—

Compare IINN vs Peers

Inspira Technologies OXY B.H.N. Ltd. (IINN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AVAV

Most directly comparable listed peer for IINN.

Scale Benchmark

vs LIN

Larger-name benchmark to compare IINN against a more recognizable public peer.

Peer Set

Compare Top 5

vs AVAV, LUNG, SPRO, GMED

Get notified when IINN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

IINN Frequently Asked Questions

Inspira Technologies OXY B.H.N. Ltd. (IINN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Inspira Technologies OXY B.H.N. Ltd.'s revenue?

Inspira Technologies OXY B.H.N. Ltd. (IINN) reported $0.3M in revenue for fiscal year 2025.

Is IINN profitable?

Inspira Technologies OXY B.H.N. Ltd. (IINN) reported a net loss of $12.6M for fiscal year 2025.

Dividend & Returns
What is IINN's return on equity?

Inspira Technologies OXY B.H.N. Ltd. (IINN) has a return on equity (ROE) of -397.9%. Negative ROE indicates the company is unprofitable.

What is Inspira Technologies OXY B.H.N. Ltd.'s free cash flow?

Inspira Technologies OXY B.H.N. Ltd. (IINN) had negative free cash flow of $10.0M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in IINN back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →